Prokaryotics is a leading brand dedicated to combating the growing threat of antibiotic drug resistance. With the rise of antibiotic-resistant bacteria, the need for innovative solutions is more urgent than ever. Prokaryotics Inc.

Their antibiotic development programs focus on targeting specific cell surface and essential biochemical assembly components of the Gram-negative outer membrane, which acts as a natural barrier for antibiotic entry. By disrupting the interdependent cellular processes involved in outer membrane biogenesis, Prokaryotics aims to develop effective monotherapeutic or synergistic antibiotic agents to combat drug-resistant bacteria. With a vision to prevent a potential 'pre-antibiotic era,' Prokaryotics is committed to providing timely and robust solutions for treating serious and life-threatening infections.

Their goal is to develop entirely new classes of antibiotics with novel mechanisms of action to ensure the efficacy of antibiotic treatment for future generations. For more information and inquiries, you can contact Prokaryotics via email at hsutterlin@prokaryotics. com or by phone at (908) 737 1922 x124.

They are located at 1075 Morris Avenue, Union, NJ 07083